Background Parkinson's disease (PD) is a prevalent neurological disease in the elderly with
increasing morbidity and mortality. Despite enormous efforts, rapid and accurate diagnosis …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease of the
central nervous system (CNS), which affects mostly older adults. In recent years, the …

Objective The pathogenesis of Parkinson's disease (PD) involves complex interactions
between environmental and genetic factors. Metabolomics can shed light on alterations in …

Progression of Parkinson's disease (PD) is highly variable, indicating that differences
between slow and rapid progression forms could provide valuable information for improved …

Parkinson's disease (PD) shows high heterogeneity with regard to the underlying molecular
pathogenesis involving multiple pathways and mechanisms. Diagnosis is still challenging …

Parkinson's disease is the second most common neurodegenerative disease. In the vast
majority of cases the origin is not genetic and the cause is not well understood, although …

The plasma of Parkinson's disease (PD) patients may contain various altered metabolites
associated with the risk or progression of the disease. Characterization of the abnormal …

The lack of knowledge about the onset and progression of Parkinson's disease (PD)
hampers its early diagnosis and treatment. Metabolomics might shed light on the PD imprint …

Biomarker research in Parkinson's disease (PD) has long been dominated by measuring
dopamine metabolites or alpha-synuclein in cerebrospinal fluid. However, these markers do …

Parkinson's disease (PD) is a common neurodegenerative disease in the elderly with a
pathogenesis that remains unclear. We aimed to explore its pathogenesis through plasma …